Don't get rid of mercury yet, says AHA (American Heart Association)
This article was originally published in Clinica
Replacing mercury sphygmomanometers with more modern aneroid or electronic instruments is not necessarily a good idea, according to an advisory statement by the American Heart Association's Council for High Blood Pressure Research. The newer types of instrument have a number of drawbacks compared with the "gold standard" mercury gravity sphygmomanometer, the Council says in the journal, Hypertension (February).
You may also be interested in...
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.